FibroGen, Inc. (FGEN)
9.01
+0.19
(+2.15%)
USD |
NASDAQ |
Dec 11, 13:42
FibroGen Price: 9.01 for Dec. 11, 2025
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Assertio Holdings, Inc. | 0.7901 |
| Perspective Therapeutics, Inc. | 2.66 |
| Skye Bioscience, Inc. | 1.175 |
| Theravance Biopharma, Inc. | 17.49 |
| Myomo, Inc. | 1.075 |
Price Related Metrics
| PE Ratio | 0.2290 |
| PS Ratio | 30.69 |
| Earnings Yield | 436.6% |
| Market Cap | 36.42M |
| Normalized PE Ratio | 0.2214 |